MedPath

Efficacy of Wet Cupping in Hypertensio

Phase 2
Conditions
Health Condition 1: I158- Other secondary hypertension
Registration Number
CTRI/2024/07/069734
Lead Sponsor
ational Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Clinically newly diagnosed patients of high blood pressure having Systolic Blood Pressure less than 160 mmHg and or diastolic blood pressure less than 100mmHg

2 Patients with abnormal lipid profile (Total cholesterol or triglycerides more than 250 mg/dl)

3 Patients between 20-65 years of age

4 Patients of either gender

5 Patients who are willing and able to sign the informed consent form

Exclusion Criteria

Patients having grade III hypertension (SBP more than or equal to 160 mmHg and /or DBP more than or equal to 100 mmHg)

2 Pregnant and lactating women

3 patients who had undergone wet cupping within the previous 6 months.

4 patients who required anti-hypertensive medication dose or type changes during the follow-up period.

5 Patients of diabetes mellitus (RBS greater than 250 mg/dl)

6 patients having any CVD or CKD of any stage.

7 patients with any localized skin lesion on the upper back (where the integrity of the skin is compromised).

8 patients who donated blood within the previous month.

9 Patients of Anemia (Hb is less than 12 mg/dl in Male and less than 10 mg/dl in Female patients.)

10 patients have bleeding diathesis, HIV infection, and hepatitis B & C infection.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 Improvement in Blood Pressures, both Systolic and Diastolic <br/ ><br>Improvement in Lipid Profile (Total cholesterol, Triglycerides, LDL Cholesterol and HDL Cholesterol) <br/ ><br>Timepoint: at baseline and after treatment
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath